Therapy News and Research

RSS

Genetic risk score can help identify women at higher risk of invasive breast cancer

Studying a person's genetic makeup can predict if they will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue.

2 Oct 2025

Boosting the immune system to prevent cancer recurrence and improve survival

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune system prevents cancer recurrence and improves survival.

30 Sep 2025

Targeting the cerebellum to ease alcohol withdrawal symptoms

By targeting a specific area of the brain, researchers at Washington State University may now hold the key to curbing the debilitating symptoms of alcohol withdrawal that push many people back to drinking.

30 Sep 2025

Sotatercept shows strong benefits for newly diagnosed pulmonary hypertension patients

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood of worsening disease when added within the first year after diagnosis, according to a study published in the New England Journal of Medicine.

30 Sep 2025

Proton therapy dose escalation may improve outcomes for glioblastoma patients

Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM).

30 Sep 2025

Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases

Genome editing is increasingly recognized as a leading frontier in biomedical research and an essential driver of healthcare innovation.

30 Sep 2025

Khat use linked to autoimmune hepatitis in young men

Khat (Catha edulis), a plant chewed for its stimulant effects by millions in East Africa and the Arabian Peninsula, is increasingly recognized for its hepatotoxic potential.

30 Sep 2025

Inflammation at the heart’s core: What clinicians and families can do now

Chronic low-grade inflammation is a key driver of cardiovascular disease, even when cholesterol is controlled. The ACC’s 2025 Scientific Statement highlights hsCRP as a routine risk marker and outlines lifestyle and pharmacologic anti-inflammatory strategies for prevention and treatment.

30 Sep 2025

Cannabis extract eases chronic back pain and improves quality of life in major clinical trial

A phase 3 trial in Nature Medicine found that a full-spectrum Cannabis sativa extract (VER-01) significantly reduced chronic low back pain and improved sleep and function compared with placebo. The extract was safe, well-tolerated, and showed no signs of abuse or dependence, with benefits maintained over long-term treatment.

30 Sep 2025

Stereotactic radiotherapy offers long-term survival outcomes comparable to surgery for NSCLC patients

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study who received radiation also reported fewer side effects after treatment.

30 Sep 2025

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Magic mushrooms may not be the answer to postpartum depression, new research from the University of California, Davis suggests.

30 Sep 2025

Discovery of EUDAL reveals new mechanism behind chemotherapy resistance in oral cancer

Oral cancer is one of the most common head and neck cancers worldwide, with hundreds of thousands of new cases diagnosed every year. Despite advances in surgery, radiotherapy, and chemotherapy, survival rates remain poor.

30 Sep 2025

Proton therapy offers no significant QOL advantage over photon therapy for breast cancer

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report equally strong health-related quality of life with either treatment. Patients who received proton therapy were more likely to say they would recommend or choose it again, but overall patient-reported outcomes were similar.

30 Sep 2025

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

The mechanical properties of tissue matrix are crucial for maintaining cell health and function. With aging, tissue matrix loses its mechanical integrity and exhibits altered biophysical properties, which are closely associated with various diseases including neurodegenerative diseases and cancers.

30 Sep 2025

Researchers design factor IX variants for short- and long-term Hemophilia B management

After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in some individuals due to hereditary factors. Hemophilia B, for example, results from a deficiency in coagulation factor IX (FIX), which can lead to prolonged bleeding after injuries or surgery.

30 Sep 2025

Therapy News and Research

Genetic risk score can help identify women at higher risk of invasive breast cancer

Boosting the immune system to prevent cancer recurrence and improve survival

Targeting the cerebellum to ease alcohol withdrawal symptoms

Sotatercept shows strong benefits for newly diagnosed pulmonary hypertension patients

Proton therapy dose escalation may improve outcomes for glioblastoma patients

Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases

Khat use linked to autoimmune hepatitis in young men

Inflammation at the heart’s core: What clinicians and families can do now

Cannabis extract eases chronic back pain and improves quality of life in major clinical trial

Stereotactic radiotherapy offers long-term survival outcomes comparable to surgery for NSCLC patients

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Discovery of EUDAL reveals new mechanism behind chemotherapy resistance in oral cancer

Proton therapy offers no significant QOL advantage over photon therapy for breast cancer

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

Researchers design factor IX variants for short- and long-term Hemophilia B management

Radiation therapy shows promise as safer alternative for severe heart rhythm disorder

Five-session SBRT reduces side effects in intermediate-risk prostate cancer

Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer

Menopause not linked to increased risk of disability in women with multiple sclerosis

New TOR inhibitor rapalink-1 prolongs chronological lifespan in fission yeast

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News